SCM
OKYO

Stonepine Capital Management’s OKYO Pharma OKYO Stock Holding History

Stonepine Capital Management’s Portfolio OKYO Stock Details OKYO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.29M Buy
862,996
+12,996
+2% +$20.8K 0.73% 34
2026
Q1 		$1.37M Buy
+850,000
New +$1.65M 0.55% 30

Other funds holding OKYO

WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
MS
Maven Securities St Helier, Jersey $5.06B AUM 59.27% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
CL
Choreo LLC Rockford, Illinois $9.11B AUM 26.3% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Stonepine Capital Management's OKYO Position: Q2 2026 in Review

Stonepine Capital Management increased its OKYO Pharma (OKYO) stake by 1.5% in Q2 2026, buying an estimated $20.8K and bringing the position to 862,996 shares worth $1.29M. The position accounts for 0.73% of the portfolio, ranked #34.

Stonepine Capital Management first reported a position in OKYO in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.37M in Q1 2026. 19 funds tracked by Wall St. Rank hold OKYO as of Q2 2026.

  • Stonepine Capital Management held 862,996 shares of OKYO Pharma worth $1.29M as of Q2 2026.
  • Stonepine Capital Management bought 12,996 OKYO Pharma shares in Q2 2026, an estimated $20.8K.
  • OKYO Pharma made up 0.73% of Stonepine Capital Management's portfolio in Q2 2026, its #34 holding.
  • Stonepine Capital Management first reported a position in OKYO Pharma in Q1 2026 and has held it in 2 quarters since.
  • Stonepine Capital Management's OKYO Pharma position peaked at $1.37M in Q1 2026.
  • 19 funds tracked by Wall St. Rank held OKYO Pharma as of Q2 2026.

Based on Stonepine Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.